Weight of evidence evaluation for chemical-induced immunotoxicity for PFOA and PFOS: findings from an independent panel of experts

References

• Abraham K, Mielke H, Fromme H, Völkel W, Menzel J, Peiser M, Zepp F, Willich SN, Weikert C. 2020. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch Toxicol. 94(6):2131–2147.
   PubMed Web of Science ®Google Scholar
• Anderson JK, Brecher RW, Cousins IT, DeWitt J, Fiedler H, Kannan K, Kirman CR, Lipscomb J, Priestly B, Schoeny R, et al. 2022. Grouping of PFAS for human health risk assessment: findings from an independent panel of experts. Regul Toxicol Pharm. 134:105226.
   PubMed Web of Science ®Google Scholar
• Anderson PO. 2019. Maternal vaccination and breastfeeding. Breastfeed Med. 14(4):215–217.
   PubMed Web of Science ®Google Scholar
• Antoniou E, Colnot T, Zeegers M, Dekant W. 2022. Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies. Arch Toxicol. 96(8):2261–2285.
   PubMed Web of Science ®Google Scholar
• [ATSDR] Agency for Toxic Substances and Disease Registry. 2021. Toxicological profile for perfluoroalkyls. [updated 2020 March]. Atlanta (GA): U.S. Department of Health and Human Services. https://www.atsdr.cdc.gov/toxprofiles/tp200.pdf
   Google Scholar
• Beck IH, Timmermann CAG, Nielsen F, Schoeters G, Jøhnk C, Kyhl HB, Høst A, Jensen TK. 2019. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort. Environ Health. 18(1):97.
   PubMed Web of Science ®Google Scholar
• Budtz-Jørgensen E, Grandjean P. 2018. Application of benchmark analysis for mixed contaminant exposures: mutual adjustment of perfluoroalkylate substances associated with immunotoxicity. PLoS One. 13(10):e0205388.
   PubMed Web of Science ®Google Scholar
• Butenhoff JL, Chang S-C, Olsen GW, Thomford PJ. 2012. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology. 293(1-3):1–15.
   PubMed Web of Science ®Google Scholar
• Butenhoff JL, Kennedy GL, Chang S-C, Olsen GW. 2012. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats. Toxicology. 298(1-3):1–13.
   PubMed Web of Science ®Google Scholar
• [CDC] Center for Disease Control and Prevention. 2022. Per- and polyfluorinated substances (PFAS) factsheet | National Biomonitoring Program | CDC [Internet]. [accessed 2022 Jul 15]. https://www.cdc.gov/biomonitoring/PFAS_FactSheet.html.
   Google Scholar
• Chang ET, Adami H-O, Boffetta P, Wedner HJ, Mandel JS. 2016. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Crit Rev Toxicol. 46(4):279–331.
   PubMed Web of Science ®Google Scholar
• DeWitt JC, Germolec DR, Luebke RW, Johnson VJ. 2016. Associating changes in the immune system with clinical diseases for interpretation in risk assessment. Curr Protoc Toxicol. 67(1):1811–18122.
   Google Scholar
• DeWitt JC, Williams WC, Creech NJ, Luebke RW. 2016. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: role of PPARα and T- and B-cell targeting. Journal of Immunotoxicology. 13(1):38–45.
   PubMed Web of Science ®Google Scholar
• Dong G-H, Wang J, Zhang Y-H, Liu M-M, Wang D, Zheng L, Jin Y-H. 2012. Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL/6 mice exposed to perfluorooctane sulfonate (PFOS). Toxicol Appl Pharmacol. 264(2):292–299.
   PubMed Web of Science ®Google Scholar
• EFSA CONTAM Panel, Schrenk D, Bignami M, Bodin L, Chipman JK, del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom L, Leblanc J-C, et al. 2020. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 18(9):e06223.
   PubMed Web of Science ®Google Scholar
• [EFSA] European Food Safety Authority. 2020. Outcome of a public consultation on the draft risk assessment of perfluoroalkyl substances in food. EFSA J. 17(9):1–202.
   Google Scholar
• [FDA] Food and Drug Administration. 2005. Biological products; bacterial vaccines and toxoids; implementation of efficacy review. Fed Regist. 70(242):75018–75028.
   Google Scholar
• Fedak KM, Bernal A, Capshaw ZA, Gross S. 2015. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 12(1):14.
   PubMedGoogle Scholar
• Fei C, McLaughlin JK, Lipworth L, Olsen J. 2010. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res. 110(8):773–777.
   PubMed Web of Science ®Google Scholar
• [FSANZ] Food Standards Australia New Zealand. 2021. PFAS and immunomodulation: review and update in support of the 27th Australian total diet study [Internet]; [accessed 2022 Mar 24]. https://www.foodstandards.gov.au/publications/Pages/27th-Australian-Total-Diet-Study.aspx.
   Google Scholar
• Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C. 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. J Am Med Assoc. 307(4):391–397.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Budtz-Jørgensen E. 2013. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health. 12(1):35.
   PubMedGoogle Scholar
• Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen Ulla B, Budtz-Jørgensen E. 2017. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect. 125(7):077018.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen Ulla B, Timmermann A, Budtz-Jørgensen E. 2017. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol. 14(1):188–195.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Timmermann CAG, Kruse M, Nielsen F, Vinholt PJ, Boding L, Heilmann C, Mølbak K. 2020. Dec 31 Severity of COVID-19 at elevated exposure to perfluorinated alkylates. PLOS One. 15(12):e0244815.
   PubMed Web of Science ®Google Scholar
• Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, van Loveren H, Løvik M, Nygaard UC. 2013. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 10(4):373–379.
   PubMed Web of Science ®Google Scholar
• Hahn-Zoric M, Fulconis F, Minoli I, Moro G, Carlsson B, Böttiger M, Rähä N, Hanson LÅ. 2008. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr. 79(12):1137–1142.
   Google Scholar
• Hanson LA. 1998. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy. Asthma Immunol. 81(6):523–537.
   PubMed Web of Science ®Google Scholar
• Hanson LA, Wiedermann U, Ashraf R, Zaman S, Adlerberth I, Dahlgren U, Wold A, Jalil F. 1996. Effects of breastfeeding on the baby and on its immune system. Food Nutr Bull. 17(4):1–5.
   Google Scholar
• Han R, Zhang F, Wan C, Liu L, Zhong Q, Ding W. 2018. Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB/TNF-α/IL-6-dependent pathway. Chemosphere. 200:283–294.
   PubMed Web of Science ®Google Scholar
• Health Canada. 2018. Guidelines for Canadian drinking water quality: guideline technical document: perfluorooctanoic acid (PFOA) [Internet]. [place unknown]: Water and Air Quality Bureau; [accessed 2020 Apr 15]. https://epe.lac-bac.gc.ca/100/201/301/weekly_acquisitions_list-ef/2018/18-51/publications.gc.ca/collections/collection_2018/sc-hc/H144-13-8-2018-eng.pdf.
   Google Scholar
• Heilmann C, Budtz-Jørgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. 2010. Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect. 118(10):1434–1438.
   PubMed Web of Science ®Google Scholar
• Jackson-Browne MS, Eliot M, Patti M, Spanier AJ, Braun JM. 2020. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013–2014. Int J Hyg Environ Health. 229:113565.
   PubMed Web of Science ®Google Scholar
• Jackson K, Nazar A. 2006. Breastfeeding, the immune response, and long-term health. J Am Osteopath Assoc. 106(4):203–207.
   PubMedGoogle Scholar
• Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. 2012. Evidence on the human health effects of low-level methylmercury exposure. Environ Health Perspect. 120(6):799–806.
   PubMed Web of Science ®Google Scholar
• Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM. 2008. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci. 103(1):77–85.
   PubMed Web of Science ®Google Scholar
• Kielsen K, Shamim Z, Ryder LP, Nielsen F, Grandjean P, Budtz-Jørgensen E, Heilmann C. 2016. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol. 13(2):270–273.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Simon TW, Hays SM. 2019. Science peer review for the 21st century: assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias. Regul Toxicol Pharm. 103:73–85.
   PubMed Web of Science ®Google Scholar
• Lee JK, Lee S, Baek MC, Lee BH, Lee HS, Kwon TK, Park PH, Shin TY, Khang D, Kim SH. 2017. Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation. J Appl Toxicol. 37(5):554–562.
   PubMed Web of Science ®Google Scholar
• Lebrec H, Molinier B, Boverhof D, Collinge M, Freebern W, Henson K, Mytych DT, Ochs HD, Wange R, Yang Y, et al. 2014. The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: study design, data analysis, interpretation. Regul Toxicol Pharm. 69(1):7–21.
   PubMed Web of Science ®Google Scholar
• Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T. 2014. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci. 138(1):76–88.
   PubMed Web of Science ®Google Scholar
• Loveless SE, Hoban D, Sykes G, Frame SR, Everds NE. 2008. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol Sci. 105(1):86–96.
   PubMed Web of Science ®Google Scholar
• Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W, et al. 1993. Risk assessment in immunotoxicology: II. Relationships between immune and host resistance tests. Toxicol Sci. 21(1):71–82.
   Google Scholar
• Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ. 1992. Risk Assessment in immunotoxicology: I. Sensitivity and predictability of immune tests. Toxicol Sci. 18(2):200–210.
   Google Scholar
• Manzano-Salgado CB, Granum B, Lopez-Espinosa MJ, Ballester F, Iñiguez C, Gascón M, Martínez D, Guxens M, Basterretxea M, Zabaleta C, et al. 2019. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study. Int J Hyg Environ Health. 222(6):945–954.
   PubMed Web of Science ®Google Scholar
• Meek MEB, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R. 2014. Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol. 34(6):595–606.
   PubMed Web of Science ®Google Scholar
• Neubert RT, Webb JR, Neubert D. 2002. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys. Hum Exp Toxicol. 21(9-10):543–567.
   PubMed Web of Science ®Google Scholar
• [NTP] National Toxicology Program. 2016. Systematic review of immunotoxicity associated with exposure to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS). [place unknown]: National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services.
   Google Scholar
• [NTP] National Toxicology Program. 2019. NTP technical report on the toxicity studies of perfluoroalkyl carboxylates (perfluorohexanoic acid, perfluorooctanoic acid, perfluorononanoic acid, and perfluorodecanoic acid) administered by gavage to Sprague Dawley (Hsd: Sprague Dawley SD) rats [Internet]. [place unknown]: National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services.
   Google Scholar
• [NTP] National Toxicology Program. 2020. NTP technical report on the toxicology and carcinogenesis studies of perfluorooctanoic acid (CASRN 335-67-1) administered in feed to Sprague Dawley (Hsd: Sprague Dawley® SD®) rats [Internet]. [place unknown]: National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services.
   Google Scholar
• [OEHHA] Office of Environmental Health Hazard Assessment. 2021. Public health goals. First public reviewed draft. Perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water [Internet]. [place unknown]: California Environmental Protection Agency. https://oehha.ca.gov/media/downloads/crnr/pfoapfosphgdraft061021.pdf.
   Google Scholar
• Post GB. 2021. Recent US state and federal drinking water guidelines for per‐ and polyfluoroalkyl substances. Environ Toxicol Chem. 40(3):550–563.
   PubMed Web of Science ®Google Scholar
• Pilkerton CS, Hobbs GR, Lilly C, Knox SS. 2018. Rubella immunity and serum perfluoroalkyl substances: sex and analytic strategy. PLOS One. 13(9):e0203330.
   PubMed Web of Science ®Google Scholar
• Qazi MR, Nelson BD, DePierre JW, Abedi-Valugerdi M. 2010. 28-Day dietary exposure of mice to a low total dose (7mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology. 267(1–3):132–139.
   PubMed Web of Science ®Google Scholar
• Smit LA, Lenters V, Høyer BB, Lindh CH, Pedersen HS, Liermontova I, Jönsson BA, Piersma AH, Bonde JP, Toft G, et al. 2015. Prenatal exposure to environmental chemical contaminants and asthma and eczema in school-age children. Allergy. 70(6):653–660.
   PubMed Web of Science ®Google Scholar
• Stein CR, McGovern KJ, Pajak AM, Maglione PJ, Wolff MS. 2016. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey. Pediatr Res. 79(2):348–357.
   PubMed Web of Science ®Google Scholar
• Suo C, Fan Z, Zhou L, Qiu J. 2017. Jul 12 Perfluorooctane sulfonate affects intestinal immunity against bacterial infection. Sci Rep. 7(1):5166.
   PubMedGoogle Scholar
• Timmermann CA, Budtz-Jørgensen E, Jensen TK, Osuna CE, Petersen MS, Steuerwald U, Nielsen F, Poulsen LK, Weihe P, Grandjean P. 2017. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J Immunotoxicol. 14(1):39–49.
   PubMed Web of Science ®Google Scholar
• Timmermann CAG, Jensen KJ, Nielsen F, Budtz-Jørgensen E, van der Klis F, Benn CS, Grandjean P, Fisker AB. 2020. Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of Guinea-Bissau children. Environ Health Perspect. 128(8):87002.
   PubMed Web of Science ®Google Scholar
• Timmermann CAG, Pedersen HS, Weihe P, Bjerregaard P, Nielsen F, Heilmann C, Grandjean P. 2022. Concentrations of tetanus and diphtheria antibodies in vaccinated Greenlandic children aged 7–12 years exposed to marine pollutants, a cross sectional study. Environ Res. 203:111712.
   PubMed Web of Science ®Google Scholar
• Torres L, Redko A, Limper C, Imbiakha B, Chang S, August A. 2021. Effect of perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice. Immunol Lett. 233:31–41.
   PubMed Web of Science ®Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 1998. Health effects test guidelines OPPTS 870.7800 immunotoxicity. [place unknown]: Prevention, Pesticides and Toxic Substances, EPA 712–C–98–351.
   Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 2005. Guidelines for carcinogen risk assessment. Washington (DC): Risk Assessment Forum. http://www.epa.gov/cancerguidelines/
   Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 2021a. External peer review draft: proposed approaches to the derivation of a draft maximum contaminant level goal for perfluorooctane sulfonic acid (PFOS) (CASRN 1763-23-1) in drinking water. Washington (DC): Office of Water, Health and Ecological Criteria Division.
   Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 2021b. External peer review draft: proposed approaches to the derivation of a draft maximum contaminant level goal for perfluorooctanoic acid (PFOA) (CASRN 335-67-1) in drinking water. Washington (DC): Office of Water, Health and Ecological Criteria Division.
   Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 2022a. Interim drinking water health advisory: perfluorooctane sulfonic acid (PFOS) CASRN 1763-23-1. Washington (DC): Office of Water (4304T), Office of Science and Technology Health and Ecological Criteria Division.
   Google Scholar
• [USEPA] U.S. Environmental Protection Agency. 2022b. Interim drinking water health advisory: perfluorooctanoic Acid (PFOA) CASRN 335-67-1. Washington (DC): Office of Water (4304T), Office of Science and Technology Health and Ecological Criteria Division.
   Google Scholar
• Weihe P, Kato K, Calafat AM, Nielsen F, Wanigatunga AA, Needham LL, Grandjean P. 2008. Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers. Environ Sci Technol. 42(16):6291–6295.
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization. 2012. Guidance for immunotoxicity risk assessment for chemicals [Internet]. Geneva: World Health Organization; [accessed 2022 Mar 14]. https://apps.who.int/iris/handle/10665/330098.
   Google Scholar
• [WHO] World Health Organization. 2018. Immunological basis for immunization series. Module 3: tetanus update; [updated 2018]. [place unknown]: World Health Organization.
   Google Scholar
• [WHO and IPCS] World Health Organization and the International Programme on Chemical Safety. 2012. Guidance for immunotoxicity risk assessment for chemicals [Internet]. Geneva: World Health Organization and the International Programme on Chemical Safety; [accessed 2022 Mar 14]. https://apps.who.int/iris/handle/10665/330098.
   Google Scholar
• Xing J, Wang G, Zhao J, Wang E, Yin B, Fang D, Zhao J, Zhang H, Chen YQ, Chen W. 2016. Toxicity assessment of perfluorooctane sulfonate using acute and subchronic male C57BL/6J mouse models. Environ Pollut. 210:388–396.
   PubMed Web of Science ®Google Scholar
• Zeng XW, Bloom MS, Dharmage SC, Lodge CJ, Chen D, Li S, Guo Y, Roponen M, Jalava P, Hirvonen MR, et al. 2019. Prenatal exposure to perfluoroalkyl substances is associated with lower hand, foot and mouth disease viruses antibody response in infancy: findings from the Guangzhou Birth Cohort Study. Sci Total Environ. 663:60–67.
   PubMed Web of Science ®Google Scholar
• Zeng XW, Li QQ, Chu C, Ye WL, Yu S, Ma H, Zeng XY, Zhou Y, Yu HY, Hu LW, et al. 2020. Apr Alternatives of perfluoroalkyl acids and hepatitis B virus surface antibody in adults: isomers of C8 health project in China. Environ Pollut. 259:113857.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xue L, Deji Z, Wang X, Liu P, Lu J, Zhou R, Huang Z. 2022. Effects of exposure to per- and polyfluoroalkyl substances on vaccine antibodies: a systematic review and meta-analysis based on epidemiological studies. Environ Pollut. 306(119442):119442.
   PubMedGoogle Scholar
• Zhong S-Q, Chen Z-X, Kong M-L, Xie Y-Q, Zhou Y, Qin X-D, Paul G, Zeng X-W, Dong G-H. 2016. Testosterone-mediated endocrine function and TH1/TH2 cytokine balance after prenatal exposure to perfluorooctane sulfonate: by sex status. Int J Mol Sci. 17(9):1509.
   PubMed Web of Science ®Google Scholar